BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

76.16M

Cash

101M

Avg Qtr Burn

-13.11M

Short % of Float

3.09%

Insider Ownership

1.16%

Institutional Own.

69.61%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Etripamil (calcium channel blocker) Details
Paroxysmal supraventricular tachycardia

NDA

Submission

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Etripamil (calcium channel blocker) Details
Atrial fibrillation

Phase 2

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Etripamil (calcium channel blocker) Details
Angina, Coronary artery disease

Failed

Discontinued

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.